John Glennon
John Glennon is a stability laboratory team leader, GlaxoSmithKline
Articles
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and Opportunities
Sarah Thompson;Nancy Lewen;Graham Cook;Andrew Teasdale;Katherine Ulman;Lance Smallshaw;Carlos W. Lee;Helmut Rockstroh;John Glennon;Samuel Powell;Cyrille C. Chéry;Laura Rutter;Laurence Harris;Vicki Woodward
March 2nd 2015Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: October 28th 2024 | Updated: November 22nd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 6th 2024 | Updated: November 22nd 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 22nd 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 22nd 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
